Everyone wants a piece of the GLP-1 pie
And CVS wants in on the weight-loss action.
Get comprehensive healthcare sector coverage—pharma, biotech, devices, services—and the policy, pipeline, and demographic drivers.
And CVS wants in on the weight-loss action.
The end of the government shutdown is the beginning of problems for healthcare stocks.
President Trump's unplanned remarks took a toll on Novo Nordisk and Eli Lilly.
Shares of the beleagured insurer popped today on the Buffett seal of approval.
The largest health insurer in the US plummeted on unexpected news.
United posted poor fiscal forecasts, while Eli Lilly's new drug could shake the weight-loss industry.
Eli Lilly rises as FDA removes competition.
Stay up to date on the latest market news with daily analysis of the investing landscape, served up Brew-style.
By subscribing, you accept our Terms & Privacy Policy.